Panagora Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,380
| Closed | -$70.9K | – | 1465 |
|
|
2022
Q4 | $70.9K | Sell |
11,380
-20,633
| -64% | -$129K | ﹤0.01% | 1419 |
|
|
2022
Q3 | $214K | Buy |
32,013
+11,342
| +55% | +$75.8K | ﹤0.01% | 1357 |
|
|
2022
Q2 | $131K | Buy |
+20,671
| New | +$131K | ﹤0.01% | 1428 |
|
|
2016
Q1 | – | Sell |
-1,591
| Closed | -$35K | – | 2304 |
|
|
2015
Q4 | $35K | Buy |
1,591
+1,052
| +195% | +$23.1K | ﹤0.01% | 2065 |
|
|
2015
Q3 | $13K | Sell |
539
-663
| -55% | -$16K | ﹤0.01% | 2196 |
|
|
2015
Q2 | $98K | Sell |
1,202
-1,484
| -55% | -$121K | ﹤0.01% | 1952 |
|
|
2015
Q1 | $249K | Buy |
2,686
+740
| +38% | +$68.6K | ﹤0.01% | 1587 |
|
|
2014
Q4 | $79K | Hold |
1,946
| – | – | ﹤0.01% | 1911 |
|
|
2014
Q3 | $47K | Sell |
1,946
-854
| -31% | -$20.6K | ﹤0.01% | 2037 |
|
|
2014
Q2 | $44K | Sell |
2,800
-1,135
| -29% | -$17.8K | ﹤0.01% | 2114 |
|
|
2014
Q1 | $59K | Buy |
3,935
+2,800
| +247% | +$42K | ﹤0.01% | 2054 |
|
|
2013
Q4 | $16K | Sell |
1,135
-13,630
| -92% | -$192K | ﹤0.01% | 2111 |
|
|
2013
Q3 | $278K | Buy |
+14,765
| New | +$278K | ﹤0.01% | 1538 |
|